Question?

Contact us if you have questions about your legal rights and Benzene Exposure.

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
13 + 7 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Acute Lymphocytic Leukemia

Acute lymphocytic leukemia (ALL) is also known as acute lymphoblastic leukemia because the disease is the result of the bone marrow producing too many immature white blood cells called lymphoblasts. These cells can be present in the blood, bone marrow, lymph nodes, spleen, as well as other organs.  Acute lymphocytic leukemia is most common in children under eleven.  However, it also affects a significant population of males over fifty.  Acute lymphocytic leukemia does not solely affect these two groups—anyone can be at risk for developing acute lymphocytic leukemia.

Symptoms

It can be difficult to recognize acute lymphocytic leukemia because many of the physical symptoms resemble common flu symptoms such as: bone pain, fatigue, fever, increased infections, and swollen lymph nodes.  There is a good chance for recovery if the leukemia is diagnosed early; however, it can progress at a rapid and fatal rate if untreated.

There are several factors that are known to increase the risk of acute lymphocytic leukemia, such as:  exposure to benzene and other industrial chemicals, genetic disorders, and exposure to radiation.  Acute lymphocytic leukemia is found more often in petroleum industry workers as a result of exposure to benzene, which is derived from petroleum.  Acute lymphocytic leukemia is also known to affect agricultural workers, distillers, dye users, furniture finishers, painters, and rubber workers.  If you believe you or a loved one has contracted acute lymphocytic leukemia or you are worried about past exposure to benzene, it is extremely important that you see a doctor and tell him/her about your medical and work history. 

 For more detailed information on this type of cancer see the National Cancer Institute's statements on ALL.